Author/Authors :
Wu, Qian Department of Respiratory Medicine - Haihe Clinical College of Tianjin Medical University, Tianjin, China , Zhong, Lingshan Tianjin Institute of Respiratory Diseases, Tianjin, China , Li, Hongwei Department of Respiratory Medicine - Haihe Clinical College of Tianjin Medical University, Tianjin, China , Guo, Jing Department of Respiratory Medicine - Haihe Clinical College of Tianjin Medical University, Tianjin, China , Li, Yajie Department of Respiratory Medicine - Haihe Clinical College of Tianjin Medical University, Tianjin, China , Hou, Xinwei Department of Respiratory Medicine - Haihe Clinical College of Tianjin Medical University, Tianjin, China , Yang, Fangfei Department of Respiratory Medicine - Haihe Clinical College of Tianjin Medical University, Tianjin, China , Xie, Yi Tianjin Institute of Respiratory Diseases, Tianjin, China , Li, Li Department of Respiratory Medicine - Haihe Clinical College of Tianjin Medical University, Tianjin, China , Xing, Zhiheng Tianjin Institute of Respiratory Diseases, Tianjin, China
Abstract :
We aimed to investigate changes in pulmonary function and computed tomography (CT) findings in patients with coronavirus
disease 2019 (COVID-19) during the recovery period. COVID-19 patients underwent symptom assessment, pulmonary function
tests, and high-resolution chest CT 6 months after discharge from the hospital. Of the 54 patients enrolled, 31 and 23 were in the
moderate and severe group, respectively. 2e main symptoms 6 months after discharge were fatigue and exertional dyspnea,
experienced by 24.1% and 18.5% of patients, respectively, followed by smell and taste dysfunction (9.3%) and cough (5.6%). One
patient dropped out of the pulmonary function tests. Of the remaining 54 patients, 41.5% had pulmonary dysfunction. Specifically,
7.5% presented with restrictive ventilatory dysfunction (forced vital capacity <80% of the predicted value), 18.9% presented with
small airway dysfunction, and 32.1% presented with pulmonary diffusion impairment (diffusing capacity for carbon monoxide
<80% of the predicted value). Of the 54 patients enrolled, six patients dropped out of the chest CT tests. Eleven of the remaining 48
patients presented with abnormal lung CT findings 6 months after discharge. Patients with residual lung lesions were more
common in the severe group (52.6%) than in the moderate group (3.4%); a higher proportion of patients had involvement of both
lungs (42.1% vs. 3.4%) in the severe group. 2e residual lung lesions were mainly ground-glass opacities (20.8%) and linear
opacities (14.6%). Semiquantitative visual scoring of the CT findings revealed significantly higher scores in the left, right, and both
lungs in the severe group than in the moderate group. COVID-19 patients 6 months after discharge mostly presented with fatigue
and exertional dyspnea, and their pulmonary dysfunction was mostly characterized by pulmonary diffusion impairment. As
revealed by chest CT, the severe group had a higher prevalence of residual lesions than the moderate group, and the residual
lesions mostly manifested as ground-glass opacities and linear opacities.
Keywords :
Lung Function , Chest Computed , Tomography , Coronavirus Disease